GlassScriptPhysician profile
Faraaz Zafar
NPI 1235792912
$3,947.87
in general payments reported to CMS, 2019-2025
21 companies · $3,437 in 2025
The $3,437 reported for 2025 was more than what 86% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $511 · 2025: $3,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,688 · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,687.90 |
| Education | $259.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $821.46 | 2024-2025 | Tremfya |
| Abbvie INC. | $511.59 | 2024-2025 | |
| Galderma Laboratories, L.P. | $400.33 | 2024-2025 | Nemluvio, Aklief |
| Ucb, INC. | $383.14 | 2024-2025 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $283.55 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $227.41 | 2025 | Sotyktu |
| Lilly USA, LLC | $191.00 | 2024-2025 | Ebglyss, Taltz |
| Organogenesis INC. | $170.39 | 2025 | Affinity, Novachor |
| Genzyme Corporation | $167.20 | 2024-2025 | |
| Kerecis Limited | $140.38 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organon LLC | $115.61 | 2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $115.39 | 2024-2025 | Libtayo, Dupixent |
| Amgen INC. | $100.96 | 2025 | Otezla |
| Novartis Pharmaceuticals Corporation | $79.55 | 2025 | |
| Pfizer INC. | $78.46 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.40 | 2025 | Spevigo |
| Convatec INC. | $30.89 | 2025 | |
| Arcutis Biotherapeutics, INC. | $29.50 | 2025 | Zoryve |
| Incyte Corporation | $24.40 | 2025 | Opzelura |
| Urgo Medical North America, LLC | $23.48 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Lnhc, INC | $16.78 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faraaz Zafar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.